De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Abbott India Beheer

Beheer criteriumcontroles 1/4

De CEO Abbott India's is Swati Dalal, benoemd in Apr2024, heeft een ambtstermijn van minder dan een jaar. bezit rechtstreeks 0% van de aandelen van het bedrijf, ter waarde ₹ 123.43K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.1 jaar en 6 jaar.

Belangrijke informatie

Swati Dalal

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	0.00002%
Management gemiddelde ambtstermijn	1.1yrs
Gemiddelde ambtstermijn bestuur	6yrs

Recente managementupdates

Recent updates

CEO

Swati Dalal

less than a year

Tenure

Ms. Swati Dalal is MD & Director of Abbott India Limited. Ms. Dalal was Director of Commercial Development of Abbott India Limited. She joined Abbott in 1995 as a Product Manager in Abbott India Limited (A...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Sridhar Kadangode	Chief Financial Officer	1.3yrs	₹23.90m	geen gegevens
Swati Dalal	MD & Director	less than a year	geen gegevens	0.000020% ₹ 124.1k
Sangeeta Shetty	Company Secretary & Compliance Officer	1.1yrs	geen gegevens	geen gegevens
Rajan Kalantre	Director of Business Human Resources	no data	geen gegevens	geen gegevens

1.1yrs

Gemiddelde duur

Ervaren management: Het managementteam van 500488 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.1 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Swati Dalal	MD & Director	less than a year	geen gegevens	0.000020% ₹ 124.1k
Ambati Venu	Non Executive Non Independent Director	8.1yrs	₹71.50m	geen gegevens
Munir Shaikh	Non-Executive Chairman of the Board	23.6yrs	₹3.20m	geen gegevens
Kaiyomarz Marfatia	Non-Executive Director	13.6yrs	₹2.30m	geen gegevens
Sudarshan Jain	Independent Non-Executive Director	5.5yrs	₹3.00m	0.0012% ₹ 7.3m
Anisha Motwani	Independent Non-Executive Director	6.5yrs	₹3.10m	geen gegevens
Shalini Kamath	Independent Non-Executive Director	5yrs	₹3.10m	geen gegevens
Alison Davies	Additional Non-Executive Director	less than a year	geen gegevens	geen gegevens

6.0yrs

Gemiddelde duur

61yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 500488 wordt beschouwd als ervaren (gemiddelde ambtstermijn 6 jaar).

Abbott India Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Abbott India Limited Announces Resignation of Ashok Saini - Commercial Director - GenNext, Vaccines and Neurolife, Effective October 16, 2024

Less than half of directors are independent

Abbott India Limited Announces Resignation of Sabina Ewing as Director, Effective June 12, 2024

Abbott India Limited, Annual General Meeting, Aug 08, 2024

Abbott India Limited Appoints Murari Ranganathan as Commercial Director

Less than half of directors are independent

Recent updates

Abbott India Limited Approves Final Dividend for Financial Year Ended March 31, 2024

Abbott India Limited to Report Q1, 2025 Results on Aug 07, 2024

Abbott India Limited Announces Resignation of Ashok Saini - Commercial Director - GenNext, Vaccines and Neurolife, Effective October 16, 2024

Less than half of directors are independent

Full year 2024 earnings released: EPS: ₹565 (vs ₹447 in FY 2023)

Upcoming dividend of ₹410 per share

Abbott India Limited Announces Resignation of Sabina Ewing as Director, Effective June 12, 2024

Abbott India Limited, Annual General Meeting, Aug 08, 2024

Full year 2024 earnings released: EPS: ₹565 (vs ₹447 in FY 2023)

Dividend increased to ₹410

Abbott India Limited Recommends Final Dividend for the Year Ended March 31, 2024, Payable on or After August 13, 2024

Abbott India Limited Recommends Final Dividend for the Year Ended March 31, 2024, Payable on or After August 13, 2024

Abbott India Limited Appoints Murari Ranganathan as Commercial Director

Less than half of directors are independent

Price target increased by 10% to ₹27,242

Abbott India Limited Announces Resignation of Sandeep Reddy - Commercial Director - Women's Health, Metabolics and International Business, with Effect from June 5, 2024

Abbott India Limited to Report Q3, 2024 Results on Feb 01, 2024

Abbott India Limited Announces Resignation of Vivek V Kamath as Managing Director, Effective from March 18, 2024

Second quarter 2024 earnings released: EPS: ₹147 (vs ₹125 in 2Q 2023)

Abbott India Limited to Report Q2, 2024 Results on Nov 09, 2023

Abbott India Limited Approves Appointment of Sangeeta Shetty as Company Secretary, Effective September 14, 2023

New major risk - Earnings quality

Abbott India Limited to Report Q1, 2024 Results on Aug 09, 2023

Abbott India Limited Appoints Ms Richa Tripathi as Associate Director, Effective August 3, 2023

Full year 2023 earnings released: EPS: ₹447 (vs ₹376 in FY 2022)

Upcoming dividend of ₹325 per share at 1.4% yield

Less than half of directors are independent

Full year 2023 earnings released: EPS: ₹447 (vs ₹376 in FY 2022)

Abbott India Limited, Annual General Meeting, Aug 09, 2023

Third quarter 2023 earnings released: EPS: ₹116 (vs ₹93.74 in 3Q 2022)

Abbott India Limited to Report Q3, 2023 Results on Feb 10, 2023

Less than half of directors are independent

Abbott India Limited to Report Q2, 2023 Results on Nov 14, 2022

Abbott India Limited Approves Final Dividend for the Financial Year Ended March 31, 2022

Abbott India Limited to Report Q1, 2023 Results on Aug 10, 2022

Upcoming dividend of ₹275 per share

Full year 2022 earnings released: EPS: ₹376 (vs ₹325 in FY 2021)

Abbott India Limited, Annual General Meeting, Aug 10, 2022

Full year 2022 earnings released: EPS: ₹376 (vs ₹325 in FY 2021)

Abbott India Limited Recommends Special Dividend for the Year Ended March 31, 2022

Abbott India Limited to Report Q4, 2022 Results on May 17, 2022

Less than half of directors are independent

Less than half of directors are independent

Abbott India Limited Appoints Vivek V Kamath as Additional Director

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Abbott India Limited to Report Q3, 2022 Results on Feb 09, 2022

Price target increased to ₹19,998

Second quarter 2022 earnings released: EPS ₹90.51 (vs ₹85.05 in 2Q 2021)

Upcoming dividend of ₹275 per share

Full year 2021 earnings released: EPS ₹325 (vs ₹279 in FY 2020)

Additional Non-Executive Director has left the company

Abbott India Limited Recommends the Payment of Final Dividend for the Year Ended March 31, 2021, Payable on and After August 3, 2021

Full year 2021 earnings released: EPS ₹325 (vs ₹279 in FY 2020)

Third quarter 2021 earnings released: EPS ₹83.36 (vs ₹87.85 in 3Q 2020)

New 90-day low: ₹14,246

Abbott India Limited to Report Q3, 2021 Results on Feb 09, 2021

New 90-day low: ₹15,009

New 90-day low: ₹15,108

Second quarter 2021 earnings released: EPS ₹85.05

New 90-day low: ₹15,162

Abbott India Limited Appoints Karen Peterson as Additional and Non-Executive Director

Abbott India Limited(BSE:500488) dropped from S&P Global BMI Index

Abbott India Limited to Report Q1, 2021 Results on Aug 07, 2020

First quarter earnings released

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden